A breakthrough Israeli-researched drug is credited for assisting former US President Jimmy Carter, a pro-Palestinian activist, in his battle with cancer.
Carter appeared on The Daily Show and discussed the recent terror attacks in Paris, citing the Israeli-Palestinian conflict as a cause for Islamic terror.